NASDAQ:SILK

Silk Road Medical (SILK) Stock Forecast, Price & News

$15.81

+0.13 (+0.83%)

(As of 02:21 PM ET)

Compare

Today's Range: $15.30
▼
$16.14
50-Day Range: $15.68
▼
$23.15
52-Week Range: $15.03
▼
$58.04

Volume: 230,065 shs
Average Volume: 663,731 shs
Market Capitalization: $613.90 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $37.60

Silk Road Medical MarketRank™ Forecast

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 137.7% Upside
$37.60 Price Target
Short Interest: Healthy
3.94% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.74
Upright™ Environmental Score
News Sentiment: 0.56
Based on 7 Articles This Week
Insider Trading: Selling Shares
$210,404 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.46) to ($1.36) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

129th out of 968 stocks

Surgical & Medical Instruments Industry

19th out of 90 stocks

4.2

Analyst's Opinion

Consensus Rating
Silk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 5 buy ratings, 2 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $37.60, Silk Road Medical has a forecasted upside of 137.7% from its current price of $15.82.
Amount of Analyst Coverage
Silk Road Medical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
3.94% of the outstanding shares of Silk Road Medical have been sold short.
Short Interest Ratio / Days to Cover
Silk Road Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Silk Road Medical has recently increased by 3.38%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Silk Road Medical does not currently pay a dividend.
Dividend Growth
Silk Road Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Silk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.
Environmental Sustainability
The Environmental Impact score for Silk Road Medical is -0.74.

3.1

News and Social Media Coverage

News Sentiment
Silk Road Medical has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Silk Road Medical this week, compared to 3 articles on an average week.
Search Interest
5 people have searched for SILK on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
MarketBeat Follows
2 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $210,404.00 in company stock.
Percentage Held by Insiders
Only 6.70% of the stock of Silk Road Medical is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Silk Road Medical are expected to grow in the coming year, from ($1.46) to ($1.36) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Silk Road Medical is -11.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Silk Road Medical is -11.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Silk Road Medical has a P/B Ratio of 3.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Price History

30 days | 90 days | 365 days | Advanced Chart

SILK Stock News Headlines

September 22, 2023 | msn.com

Argus Research Downgrades Silk Road Medical (SILK)

September 21, 2023 | finance.yahoo.com

Silk Road Medical, Inc: Downgrading to HOLD from BUY

September 22, 2023 | UNKNOWN (Ad)

Space CEO Featured on Good Morning America

A $25 Billion Earth Observation Market by 2040. Learn more

September 21, 2023 | finance.yahoo.com

Enphase Energy upgraded, Brighthouse downgraded: Wall Street's top analyst calls

September 7, 2023 | msn.com

Oppenheimer Initiates Coverage of Silk Road Medical (SILK) with Outperform Recommendation

September 6, 2023 | markets.businessinsider.com

Analyst Expectations for Silk Road Medical's Future

September 6, 2023 | markets.businessinsider.com

Medical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: Analyst

September 4, 2023 | finance.yahoo.com

Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference

September 22, 2023 | UNKNOWN (Ad)

Space CEO Featured on Good Morning America

A $25 Billion Earth Observation Market by 2040. Learn more

August 10, 2023 | msn.com

Silk Road Medical: Unsure On Economics Given List Of Probabilities (Rating Downgrade)

August 3, 2023 | msn.com

Silk Road Medical (SILK) Price Target Decreased by 15.22% to 39.78

August 2, 2023 | finance.yahoo.com

Q2 2023 Silk Road Medical Inc Earnings Call

August 2, 2023 | finance.yahoo.com

Silk Road Medical, Inc (NASDAQ:SILK) Q2 2023 Earnings Call Transcript

August 2, 2023 | markets.businessinsider.com

Bank of America Securities Sticks to Its Sell Rating for Silk Road Medical (SILK)

August 2, 2023 | msn.com

Silk Road Medical GAAP EPS of -$0.35 beats by $0.03, revenue of $45.3M beats by $2.13M

August 1, 2023 | finance.yahoo.com

Silk Road Medical Reports Second Quarter 2023 Financial Results

July 31, 2023 | markets.businessinsider.com

B.Riley Financial Reaffirms Their Buy Rating on CareCloud (CCLD)

July 25, 2023 | fool.com

Silk Road Medical (NASDAQ: SILK)

July 18, 2023 | markets.businessinsider.com

Wolfe Research Reaffirms Their Sell Rating on Silk Road Medical (SILK)

July 14, 2023 | sg.finance.yahoo.com

SILK - Silk Road Medical, Inc

July 13, 2023 | msn.com

B of A Securities Downgrades Silk Road Medical (SILK)

July 12, 2023 | msn.com

Silk Road Medical falls after Medicare decision on stroke treatment

July 12, 2023 | markets.businessinsider.com

Why Silk Road Medical Stock Is Plunging Today

July 12, 2023 | markets.businessinsider.com

B.Riley Financial Sticks to Their Buy Rating for Silk Road Medical (SILK)

July 12, 2023 | msn.com

Biggest stock movers today: CBL International and Silk Road Medical

July 11, 2023 | msn.com

Citigroup Reiterates Silk Road Medical (SILK) Buy Recommendation

July 11, 2023 | finance.yahoo.com

Silk Road Medical to Report Second Quarter 2023 Financial Results on August 1, 2023

See More Headlines

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings: 8/01/2023
Today: 9/22/2023
Next Earnings (Estimated): 11/14/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SILK
CUSIP: N/A
CIK: 1397702
Web: www.silkroadmed.com
Phone: (408) 720-9002
Fax: 408-720-9013
Employees: 414
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $37.60
High Stock Price Forecast: $55.00
Low Stock Price Forecast: $13.00
Forecasted Upside/Downside: +139.8%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.41)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-55,010,000.00
Net Margins: -32.83%
Pretax Margin: -32.47%
Return on Equity: -40.05%
Return on Assets: -22.40%

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 9.69
Quick Ratio: 8.90

Sales & Book Value

Annual Sales: $138.64 million
Price / Sales: 4.39
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.30 per share
Price / Book: 3.65

Miscellaneous

Outstanding Shares: 38,830,000
Free Float: 36,231,000
Market Cap: $608.85 million
Optionable: Not Optionable
Beta: 1.16

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Ms. Erica J. Rogers (Age 60)
Pres, CEO & Director
Comp: $1.17M

Mr. Lucas W. Buchanan (Age 45)
CFO & COO
Comp: $870.55k

Mr. Kevin M. Klemz (Age 62)
EVP, Chief Legal Officer & Sec.
Comp: $644.12k

Mr. Andrew S. Davis (Age 54)
Chief Commercial Officer
Comp: $836.33k

Mr. Richard M. Ruedy (Age 56)
Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
Comp: $542.41k

Ms. Mhairi L. Jones (Age 52)
Chief Accounting Officer & VP of Fin.

Ms. Tammy Leitsinger
Compliance Officer & VP of Medical Affairs

Mr. Matthew McCarthy
VP of Marketing

Ms. Alison Highlander
VP of HR

Dr. Sumaira MacDonald M.D.
Ph.D., Exec. Medical Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings or view top-rated stocks.
What is Silk Road Medical's stock price forecast for 2023?: 9 brokerages have issued 1-year price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $13.00 to $55.00. On average, they expect the company's stock price to reach $37.60 in the next twelve months. This suggests a possible upside of 139.8% from the stock's current price.
View analysts price targets for SILK or view top-rated stocks among Wall Street analysts.
How have SILK shares performed in 2023?: Silk Road Medical's stock was trading at $52.85 on January 1st, 2023. Since then, SILK stock has decreased by 70.3% and is now trading at $15.68.
View the best growth stocks for 2023 here.
When is Silk Road Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our SILK earnings forecast.
How were Silk Road Medical's earnings last quarter?: Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. The company earned $45.30 million during the quarter, compared to analyst estimates of $43.32 million. Silk Road Medical had a negative net margin of 32.83% and a negative trailing twelve-month return on equity of 40.05%.
What ETFs hold Silk Road Medical's stock?: ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American CenturyFocused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI).
What guidance has Silk Road Medical issued on next quarter's earnings?: Silk Road Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180.00 million-$184.00 million, compared to the consensus revenue estimate of $179.54 million.
What other stocks do shareholders of Silk Road Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?: (SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.
What is Silk Road Medical's stock symbol?: Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."
Who are Silk Road Medical's major shareholders?: Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (49.17%), Wasatch Advisors LP (13.55%), BlackRock Inc. (7.64%), Alliancebernstein L.P. (6.42%), Clearbridge Investments LLC (4.47%) and Bellevue Group AG (3.49%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin M Klemz, Lucas W Buchanan, Richard Ruedy and Tony M Chou.
View institutional ownership trends.
How do I buy shares of Silk Road Medical?: Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Silk Road Medical's stock price today?: One share of SILK stock can currently be purchased for approximately $15.68.
How much money does Silk Road Medical make?: Silk Road Medical (NASDAQ:SILK) has a market capitalization of $608.85 million and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.41) on an earnings per share basis.
How many employees does Silk Road Medical have?: The company employs 414 workers across the globe.
How can I contact Silk Road Medical?: Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial